Related Experiment Videos

Standard cardiac rehabilitation is less effective for diabetics

V Suresh1, R A Harrison, P Houghton

  • 1Department of Cardiology, Wigan and Leigh NHS Trust Wigan, Wigan Lane, Wigan, Lancs WN1 2NN, UK.

Insights

Diabetic patients experienced poorer outcomes in standard cardiac rehabilitation programs after myocardial infarction (MI). These patients had less medication, lower smoking cessation rates, and higher mortality, suggesting a need for specialized programs.

Area of Science:

  • Cardiology
  • Diabetology
  • Public Health

Background:

  • Myocardial infarction (MI) is a leading cause of mortality globally.
  • Cardiac rehabilitation (CR) improves outcomes for post-MI patients.
  • Diabetes mellitus is a significant risk factor for cardiovascular disease and impacts CR effectiveness.

Purpose of the Study:

  • To evaluate clinical outcomes and lifestyle modifications in diabetic patients undergoing standard CR post-MI.
  • To compare the effectiveness of standard CR for diabetic versus non-diabetic patients.
  • To identify specific areas where standard CR falls short for diabetic individuals.

Main Methods:

  • Retrospective longitudinal study design.
  • Analysis of data from 1804 patients (223 with diabetes) attending CR over 10 years.
  • Comparison of medication adherence, lifestyle modifications (smoking cessation, physiotherapy), and mortality rates between diabetic and non-diabetic groups.

Main Results:

  • Diabetic patients received significantly less aspirin and beta-blocker therapy (p < 0.0001).
  • Smoking cessation rates were lower (54.2% vs 69.1%, p < 0.003) and physiotherapy attendance was reduced (26.9% vs 58.6%, p < 0.0001) in diabetics.
  • Diabetic patients exhibited higher one-year mortality (15.7% vs 5.6%, p < 0.0001), primarily due to cardiovascular disease.

Conclusions:

  • Standard CR programs are less effective for patients with diabetes mellitus.
  • Specialized rehabilitation programs are needed to integrate chronic condition management with MI care.
  • Aggressive, evidence-based pharmacotherapy should be prioritized for all post-MI patients, including those with diabetes.

Related Concept Videos